Pfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion
Print/Download(Bloomberg) — Pfizer Inc., maker of a top-selling Covid vaccine, will buy all the shares of Trillium Therapeutics Inc. it doesnt own, gaining the immune cancer drugmaker for an equity value of $2.26…
Read More
